HENDERSON, Nev., July 8, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Vaccines-2014 will bring together all vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers to conduct this Scientific & Business Meeting. This meeting will pave a way to make discussions and developments in the arena of vaccines for the next era.
Reputed speakers in this field including Dr. Alexander Von Gabain, European Institute of Innovation and Technology, Europe; Dr. Ray Spier, Former President International Society for Vaccines, UK; Dr. Roy Curtiss III, Arizona State University, USA; Dr. Charung Muangchana, National Vaccine Institute, Thailand; Dr. Michael G Hanna, Vaccinogen Inc., USA; Dr. Nikolai Petrovsky, Flinders University, Australia and Dr. Maurizio Chiriva-Internati, Texas Tech University, USA, who will be delivering keynote speeches adding value and zeal to this Scientific Meeting.
Vaccines-2014 will focus on several interesting topics such as Vaccine Adjuvants; Veterinary Vaccines; Therapeutic Vaccines for Chronic Infections; Cancer Vaccines; Bio-defense Vaccine; AIDS/HIV Vaccine; Vaccine Antigen Modeling; Immuno-informatics in Vaccine Design; Vaccine Formulation Issues; Unconventional Vaccines and many more intriguing topics on Vaccines.
Aficionados who are going to mark their presence in this pragmatic International Clinical Conference include Alan R Shaw, Vedantra Pharmaceuticals, USA; Siwicki Andrzej Krzyszt of, University in Olsztyn, Poland; Magdalena Tary-Lehmann, Cellular Technology Limited, USA; Brain K Meyer, Merck Inc., USA; Harry Kleanthous, Sanofi Pasteur Inc., USA; Frank Appel, Merck Millipore, Germany; Jean L Patterson, Texas Biomedical Research Institute, USA; Geert Vanden Bossche, UNIVAC IIc, Belgium; Jeffrey Ulmer, Novartis Vaccines, USA; Yuzhang Wu, Third Military Medical University, China; Wei Kong, Arizona State University, USA; Leonard A Smith, US Army Medical Research Institute of Infectious Diseases, USA; Nathaly Arndtz Wiedemann, Bavarian Nordic GmbH, Germany and more from over 50 countries.
After three successful vaccine conferences organized by OMICS Group, Vaccines-2014 will bring together the horizon of scientific berg including scientists, researchers and professors and the world of business, comprising of vaccine stakeholders, vaccine policy makers, and vaccine manufacturers. In association with the Vaccines-2014 meeting, there is an opportunities for the speakers to publish their research work in OMICS Group Peer Reviewed journal such as the Journal of Vaccines and Vaccination or its sister publication, Journal of Clinical & Cellular Immunology, Immune Research and Journal of Immunological Techniques in Infectious Diseases.
These Scientific Conferences organized by OMICS Group facilitate young researchers and scholars to interact with the world class experts in respective fields to evaluate their research through the Young Research Forum, Best Poster Award Competition and Student Fellowship, thus encouraging student participation in the scientific research and development.
We invite eminent personalities in the field of vaccines and vaccination to participate as speakers/delegates and also to conduct international workshops on related scientific sessions of the conference. This event edges out the aspects of setting up a successful B2B environment to evaluate the participants and increase their probability of making high-quality business connections.
We would like to invite you to have a glance at the Scientific Program to see the list of scientific eminence marking their presence in this pragmatic International Clinical Conference.
For more details and for further information related to Vaccines-2014, please contact
Venkatesh
Vaccines-2014
Clinical Conferences
2360 Corporate Circle Suite,
400 Henderson, NV 89074-7722, USA
Office:+1-888-843-8169
Fax: +1-650-618-1414
E-mail: vaccines2014(at)omicsonline(dot)net
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/OMICS-Group/Vaccines-2014/prweb11999157.htm